alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 72, Number 55 (Thursday, March 22, 2007)]
[Notices]
[Page 13503]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-1410]



[[Page 13503]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 52b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Inherited Disease Research Access 
Committee, CIDR Group A.
    Date: May 3-4, 2007.
    Time: May 3, 2007, 7 p.m. to 9 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 740 
Wisconsin Avenue, Bethesda, MD 20814.
    Time: May 4, 2007, 8:30 a.m. to 1:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 740 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Jerry Roberts, PhD, Scientific Review 
Administrator, Scientific Review Branch, National Institutes of 
Health, Building 38A, Bethesda, MD 20892, 301 402-0838.

    Name of Committee: Center for Inherited Disease Research Access 
Committee, CIDR B.
    Date: May 4, 2007.
    Time: 2 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 740 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Rudy Pozzatti, PhD, Scientific Review 
Administrator, Scientific Review Branch, National Human Genome 
Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, 
Bethesda, MD 20852, (301) 402-0838.<a href="/cdn-cgi/l/email-protection#50203f2a2a31242422103d31393c7e3e39387e373f26"><span class="__cf_email__" data-cfemail="cbbba4b1b1aabfbfb98ba6aaa2a7e5a5a2a3e5aca4bd">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: March 15, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1410 Filed 3-21-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32.1**

**Written Statement of the Chief Executive and Acting Chief Financial Officer Pursuant to 18 U.S.C.  1350**

Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Principal Executive Officer and Acting Principal Financial Officer of Human BioSystems (the "Company"),  hereby certify, based on  my  knowledge,  that  the Quarterly  Report  on Form 10-QSB of the Company  for  the  quarter ended  September 30, 2006 (the "Report") fully complies  with  the requirements of Section 13(a) of the Securities Exchange Act  of 1934   and  that  information  contained  in  the  Report  fairly presents,  in all material respects, the financial condition  and results of operations of the Company.

Date: November 14, 2006 

/s/Harry Masuda 

Harry Masuda 

Chief Executive Officer and Acting Chief Financial Officer
§ 681.25 Where is the hearing held? The ALJ will hold the hearing in any judicial district of the United States: ( a ) In which the defendant resides or transacts business; or
( b ) In which the claim or statement on which liability is based was made to NSF; or
( c ) As agreed upon by the defendant and the ALJ.
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JAN-31-1999
<PERIOD-START>                             FEB-01-1998
<PERIOD-END>                               JAN-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                           2,424
<SECURITIES>                                         0
<RECEIVABLES>                                    1,512
<ALLOWANCES>                                         0
<INVENTORY>                                      8,404
<CURRENT-ASSETS>                                14,427
<PP&E>                                          25,364
<DEPRECIATION>                                   7,472
<TOTAL-ASSETS>                                 165,680
<CURRENT-LIABILITIES>                           31,178
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           142
<OTHER-SE>                                      76,114
<TOTAL-LIABILITY-AND-EQUITY>                   165,680
<SALES>                                         18,626
<TOTAL-REVENUES>                                20,174
<CGS>                                           14,414
<TOTAL-COSTS>                                  141,344
<OTHER-EXPENSES>                                   345
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,674
<INCOME-PRETAX>                               (28,189)
<INCOME-TAX>                                     (972)
<INCOME-CONTINUING>                           (27,217)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (27,217)
<EPS-PRIMARY>                                   (1.93)
<EPS-DILUTED>                                   (1.93)
        

</TABLE>
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A15D0488. MAHMOUD HAFEZ v. THE STATE.

Mahmoud Hafez seeks discretionary review of the trial court’s order denying

his extraordinary motion for new trial. We lack jurisdiction because the application

is untimely.

An application for discretionary appeal must be filed within 30 days of the

entry of the order or judgment to be appealed. See OCGA § 5-6-35 (d). The

requirements of OCGA § 5-6-35 are jurisdictional, and this Court cannot accept an

application for appeal not made in compliance therewith. See Boyle v. State, 190 Ga.

App. 734 (380 SE2d 57) (1989). Here, the trial court’s order was entered on May 18,

2015, and Hafez filed his application on June 29, 2015, which was 42 days later.

Therefore, the application is untimely, and it is hereby DISMISSED for lack of

jurisdiction.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

07/27/2015

July 27, 2015
----

----

| Dated      as of February 27, 2009            |   |   |
|-----------------------------------------------|--------|--------|
|                                          |   |   |
|                                          |   |   |
| /s/  Joseph L.      Sullivan        |   |   |
| Joseph      L. Sullivan                       |   |   |
|                                          |   |   |
| /s/  Patrick J.      Goodman        |   |   |
| Patrick      J. Goodman                       |   |   |
|                                          |   |   |
| /s/ Eulogio Wilfredo G.    Sarmago            |   |   |
| Eulogio      Wilfredo G. Sarmago              |   |   |
|                                          |   |   |
| /s/  Trinity S.    Gatuz            |   |   |
| Trinity      S. Gatuz                         |   |   |
|                                          |   |   |
| /s/  Belinda E.    Dugan            |   |   |
| Belinda      E. Dugan                         |   |   |
|                                          |   |   |
| /s/  Suzy Lyn A.      Bayona-Salova |   |   |
| Suzy      Lyn A. Bayona-Salova                |   |   |
|                                          |   |   |
| /s/  P. Eric    Connor              |   |   |
| P.      Eric Connor                           |   |   |
|                                          |   |   |
|                                          |   |   |
|                                          |   |   |
|                                          |   |   |
|                                          |   |   |

----

----
### Executiv e Orde r 1286 6 an d Congressiona l Review Requirement s Rulemakin g Documen t

Title : tajhanclu RAirlin e PassenRc r Brotectlons : Limite dExtensio n o f Effec t Dat e Fo r

Ful l Far e Pric e Advertisin g RIN : 2105-AD9 2 Withrespec t

t o th e attache drulemakin g document(s) : 1 . E.O . 12866 : Th e requirement s o f sectio n6(a)(3)(E ) o f

E.O . 1286 6 hav e bee nme t inaccordanc e wit

hth e followin g [initia l appropriat e line] ;

y ^ Th e rulemakin g document(s ) wa s no t reviewe db y th e Offic e o f Informatio nan d Regulator y Affair s (OIRA) . N o substantiv e change s wer e mad e t o th e document(s ) after i t wa s submitte dt o OIRA . Th e require dinformatio ni s attached . 2 . Congressiona l Review : Th e requirement s o f th e Smal l Busines s Regulator y Enforcemen t Fairnes s Ac t for th e submissio n o f

final rule s t o Congres s an dGA O ( § 801 ) hav e bee nme t inaccordanc e withth e followin g [initial appropriat e line] :

Thi s documen t

i s no t afinal rule . Thi s documen t

i s no t arul e unde r

( § 804) . / \Th e documen t

ha s bee nsubmitte dt o C-5 0 for transmissio nt o Congres s an dGAO .

Signatur e Blan e A . Nam e Deput y A s Title/Offic e Decembe r Workl e

slstan t Genera l 1 3 . 201 1 Counse l

Dat e
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Balance Sheet at June 30, 1999 (unaudited) and the Statement of
Operations for the three months ended June 30, 1999 (unaudited) and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                                    <C>
<PERIOD-TYPE>                          6-MOS
<FISCAL-YEAR-END>                      DEC-31-1999
<PERIOD-END>                           JUN-30-1999
<CASH>                                 532,000
<SECURITIES>                           0
<RECEIVABLES>                          232,000
<ALLOWANCES>                           0
<INVENTORY>                            948,000
<CURRENT-ASSETS>                       1,712,000
<PP&E>                                 1,105,000
<DEPRECIATION>                         99,000
<TOTAL-ASSETS>                         3,164,000
<CURRENT-LIABILITIES>                  501,000
<BONDS>                                0
<PREFERRED-MANDATORY>                  0
<PREFERRED>                            0
<COMMON>                               2,572,000
<OTHER-SE>                             0
<TOTAL-LIABILITY-AND-EQUITY>           3,164,000
<SALES>                                1,412,000
<TOTAL-REVENUES>                       1,412,000
<CGS>                                  533,000
<TOTAL-COSTS>                          1,304,000
<OTHER-EXPENSES>                       0
<LOSS-PROVISION>                       0
<INTEREST-EXPENSE>                     (6,000)
<INCOME-PRETAX>                        108,000
<INCOME-TAX>                           0
<INCOME-CONTINUING>                    0
<DISCONTINUED>                         0
<EXTRAORDINARY>                        0
<CHANGES>                              0
<NET-INCOME>                           108,000
<EPS-BASIC>                          0,01
<EPS-DILUTED>                          0.01



</TABLE>
---

---

# Exhibit 11

# Statement of Computation
of Earnings per Share (in thousands)

Following is the data relating to the
weighted average number of shares used in the computation of diluted earning (loss) per
share:

|                                                   | Year ended
December 31,
2008 | Year ended
December 31,
2007
|-------------------------------------------------- | ---------------------------- | ----------------------------
|
|
|
|
|Weighted average number of shares used in the      |                              |                             
|computation of basic earning (loss) per share      |                              |                             
|                                                   |                              |                             
|Add: Net additional shares from the anticipated    |                              |                             
|exercise of stock options                          |                              |                             
|                                                   |                              |                             
|Weighted average number of shares used in the      |                              |                             
|computation of diluted earning per share           |                              |                             
|                                                   |                              |                             
|                                                   |                              |                             
|Options which were not included in the computation |                              |                             
|of diluted earning (loss) per share due to anti    |                              |                             
|dilutive effect                                    |                              |                             
|                                                   |                              |                             



---

---
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.403 Filed 04/19/16 Page 1 of 6
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.404 Filed 04/19/16 Page 2 of 6
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.405 Filed 04/19/16 Page 3 of 6
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.406 Filed 04/19/16 Page 4 of 6
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.407 Filed 04/19/16 Page 5 of 6
Case 2:14-cv-13005-AC-MKM ECF No. 41-4, PageID.408 Filed 04/19/16 Page 6 of 6
UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF MICHIGAN

SOUTHERN DIVISION

MICHAEL THREET, No. 14-13345

v. District Judge Bernard A. Friedman

Magistrate Judge R. Steven Whalen

D. PHILLIPS, ET AL.,

Defendants.

 /

ORDER 

Before the Court are Plaintiff Michael Threet’s two motions to compel discovery

[Doc. #45 and Doc. #46], both of which were filed on February 12, 2016. Previously, the

Court entered an order staying discovery [Doc. #38] pending resolution of Defendants’

motion to dismiss [Doc. #33]. On February 1, 2016, the Court granted in part and denied

in part the motion to dismiss [Doc. #44]. Because a party has 30 days to respond to

interrogatories and requests to produce, Plaintiff’s February 12, 2016 motions to compel,

filed less than two weeks after the stay of discovery dissolved, were premature. In

addition, the only Defendants that survived the motion to dismiss are Defendants Phillips,

Richardson, Hurst, and Bruner; thus, it is only these four Defendants to whom the

pending discovery requests are properly directed.

Therefore, Plaintiff’s motions to compel [Doc. #45 and Doc. #46] are DENIED

WITHOUT PREJUDICE. 

-1-

2:14-cv-13345-BAF-RSW Doc # 64 Filed 06/20/16 Pg 1 of 2 Pg ID 679
Of course, more than 30 days have now elapsed since the Plaintiff made his

discovery requests. To the extent that the remaining Defendants have not yet responded,

they must do so within 14 days of the date of this Order. If they do not, Plaintiff may

renew his motions to compel.

IT IS SO ORDERED.

Dated: June 20, 2016 s/R. Steven Whalen 

R. STEVEN WHALEN

UNITED STATES MAGISTRATE JUDGE

CERTIFICATE OF SERVICE

I hereby certify on June 20, 2016 that I electronically filed the foregoing paper

with the Clerk ofthe Court sending notification ofsuch filing to all counsel registered

electronically. I hereby certify that a copy of this paper was mailed to the following

non-registered ECF participants June 20, 2016.

s/Carolyn M. Ciesla 

Case Manager for the 

Honorable R. Steven Whalen 

-2-

2:14-cv-13345-BAF-RSW Doc # 64 Filed 06/20/16 Pg 2 of 2 Pg ID 680
§ 11.502 General requirements for national engineer endorsements. ( a ) For all original and raise of grade of engineer endorsements, at least one-third of the minimum service requirements must have been obtained on the particular mode of propulsion for which the applicant seeks endorsement.
( b ) If an applicant desires to add a propulsion mode (steam, motor, or gas turbine) to his or her endorsement while holding a license or MMC officer endorsement in that grade, the following alternatives are acceptable: ( 1 ) Four months of service as an observer on vessels of the new propulsion mode.
( 2 ) Four months of service as an engineer officer at the operational level on vessels of the new propulsion mode.
( 3 ) Six months of service as oiler, fireman/watertender, or junior engineer on vessels of the new propulsion mode.
( 4 ) Completion of a Coast Guard-approved training course for this endorsement.
#### § 112.40-1 General requirements.

Installations requiring alternating current for the operation of communication equipment or other apparatus essential under temporary emergency conditions must be provided with the necessary conversion equipment. If the conversion equipment operates both under normal conditions and under temporary emergency conditions, the conversion equipment must be provided in duplicate.
#### § 108.457 Pressure release.

Each air tight or vapor tight space, such as a paint locker, that is protected by a CO2 system must have a means for releasing pressure that accumulates within the space if CO2 is discharged into the space.
§ 13.505 Proof of service for tankerman-engineer endorsement. ( a ) Service must be proved by a letter on company letterhead from the owner, operator, master, or chief engineer of a tankship or self-propelled tank vessel. The letter must specify— ( 1 ) The classification of cargo (DL, LG, or both) carried while the applicant accumulated the service; and
( 2 ) The number of days of officer, rating, and cadet service in the engine department on tankships or self-propelled tank vessels; or
( b ) Service must be proved by certificates of discharge from tankships or self-propelled tank vessels with the appropriate classification of cargo (DL, LG, or both).
[CGD 79-116, 60 FR 17142, Apr. 4, 1995, as amended by CGD 79-116, 62 FR 25135, May 8, 1997; USCG-2006-24371, 74 FR 11260, Mar. 16, 2009]
§ 122.115 Applicability; preemptive effect. ( a ) An existing vessel need not comply with the hull marking requirements in § 122.602(c) until completion of a vessel's first drydock required by § 115.600 of this chapter that occurs after March 11, 1996.
( b ) An existing vessel need not comply with the marking requirements in §§ 122.604 and 122.610, where the size and contents of the markings required by §§ 122.604 and 122.610 vary from the size and contents of required markings on lifesaving equipment, watertight doors, and watertight hatches on the vessel prior to March 11, 1996, until the existing markings are no longer legible, as determined by the cognizant Officer in Charge, Marine Inspection (OCMI).
( c ) An existing vessel need not comply with the requirements of §§ 122.514, 122.515, 122.516, and 124.604(j) until completion of the first inspection for certification that occurs after March 11, 1996.
( d ) The regulations in this part have preemptive effect over State or local regulations in the same field.
[CGD 85-080, 61 FR 935, Jan. 10, 1996; 61 FR 24464, May 15, 1996; USCG-2006-24797, 77 FR 33884, June 7, 2012]
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection  with the Quarterly  Report of Health Express USA, Inc. (the
"Company") on Form 10-QSB for the quarter ended September 26, 2004 as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  the
undersigned,  in the  capacities  and  on  the  dates  indicated  below,  hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:

      1. The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      2.  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of  operation of the
Company.

Date: November 8, 2004                            By:    /s/ Douglas Baker
                                                         -----------------------
                                                  Name:  Douglas Baker
                                                  Title: Chief Executive Officer


Date: November 8, 2004                            By:    /s/ Patricia Durante
                                                         -----------------------
                                                  Name:  Patricia Durante
                                                  Title: Chief Financial Officer


A signed  original of this written  statement  required by Section 906, or other
document  authentications,  acknowledging,  or otherwise  adopting the signature
that  appears  in typed  form  within the  electronic  version  of this  written
statement required by Section 906, has been provided to Health Express USA, Inc.
and will be retained by Health Express USA, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.


                                 EXHIBIT 32.1-1
EX-10.4





 Exhibit 10.4 

AMENDMENT NO. 5 TO THE CYTODYN INC. 

2012 EQUITY INCENTIVE PLAN 

Dated: June 16, 2020 
 Pursuant to
Article 12 of the 2012 Equity Incentive Plan (the “Plan”) of CytoDyn Inc., the Board of Directors hereby amends the Plan as follows: 
 1.
Section 13.9 of the Plan is hereby amended in its entirety to read as follows: 
 13.9    Governing Law.
Except with respect to references to the Code or federal securities laws, the Plan and all actions taken thereunder will be governed by and construed in accordance with the laws of the state of Delaware, without regard to principles of conflict of
laws. 
 2. Sections 6.8 and 8.7 of the Plan are deleted in their entirety. 

IN WITNESS WHEREOF, the undersigned has executed this Amendment No. 5 as evidence of its adoption by the Board of Directors of the Company on the date
set forth above. 
  

			
	CytoDyn Inc.
		
	By:	 	 /s/ Arian Colachis

		 	General Counsel and Secretary